Middle East Pharmaceutical Industries Co. (4016.SR)
SAR 120.2
(-0.5%)
SAR 120.2
(-0.5%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 59.77 Million SAR | -29.65% |
| 2022 | 84.97 Million SAR | -2.37% |
| 2021 | 87.03 Million SAR | 38.92% |
| 2020 | 62.65 Million SAR | 398.79% |
| 2019 | 12.56 Million SAR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 48.85 Million SAR | -18.27% |
| 2024 Q2 | 6.33 Million SAR | -87.03% |
| 2023 Q4 | 59.77 Million SAR | 0.0% |
| 2023 Q1 | - SAR | -100.0% |
| 2023 Q3 | 59.77 Million SAR | -18.23% |
| 2023 Q2 | 73.1 Million SAR | 0.0% |
| 2023 FY | 59.77 Million SAR | -29.65% |
| 2022 Q3 | 84.97 Million SAR | 0.0% |
| 2022 FY | 84.97 Million SAR | -2.37% |
| 2022 Q4 | 84.97 Million SAR | 0.0% |
| 2022 Q1 | - SAR | 0.0% |
| 2021 FY | 87.03 Million SAR | 38.92% |
| 2020 FY | 62.65 Million SAR | 398.79% |
| 2019 FY | 12.56 Million SAR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Al-Dawaa Medical Services Company | 2.29 Billion SAR | 97.394% |
| Nahdi Medical Company | 1.17 Billion SAR | 94.911% |
| Al-Razi Medical Co. | 11.72 Million SAR | -409.958% |
| Almujtama Alraida Medical Co. | 168.88 Million SAR | 64.604% |